Optometry Connection September 2026
Available from: 1/09/2026 (AEST)
Where to publish: https://lms.optometry.org.au/course/view.php?id=1047
Provider: OA National Provider
Contact: Optometry Australia Optometry Australia, [E] cpd@optometry.org.au, [P] 96688550
Activity Outline
Optometrist reads Optometry Connection educational publication in print or online.Optometrist logs into OA Institute of Excellence and completes assessment questions developed from articles in Optometry Connection.
Optometrist will receive immediate confirmation upon completion and CPD Hours will be uploaded to the Learning Plan of their CPD Portfolio. Optometrists completing online assessment will be able to review incorrect answers and have an opportunity to repeat the assessment activity in line with adult learning principles and OBA guidelines. Opportunity to provide feedback and commentary provided by standard OA Institute of Excellence CPD Activity Feedback Form.
Learning Objectives
- Understand the potential ocular adverse effects of topical anti-glaucoma medications
- Adopt an optometry-focussed, stepwise treatment algorithm for managing ocular adverse effects from anti-glaucoma medications, including ocular surface disease treatment, intra- and inter-class glaucoma medication changes, use of preservative-free or combination glaucoma medications, and recognising potential benefits of oral medications
- Recognise clinical indications for ophthalmology referral in cases of refractory ocular surface disease related to anti-glaucoma medications
- Recognise the role of optometrists in the early detection and referral of stroke patients presenting with visual symptoms, and apply the BE-FAST framework to identify potential stroke presentations.
- Understand the importance of visual field assessment in the diagnosis, management, and monitoring of stroke-related visual field defects
- Confidently define, identify, and manage pre-myopia, including the appropriate application of optical and pharmacological myopia control treatments.
- Understand binocular vision factors that may influence myopia-management selection, comfort and compliance in paediatric patients
- Recognise when ongoing myopia progression during treatment warrants reassessment of adherence, risk factors and potential escalation to alternative or combination therapy.
- Identify and describe barriers to accessing myopia control treatment, including poor health literacy, financial constraints, and language barriers
- Identify the role of optometrists in preventing vision loss associated with pathological myopia
Max CPD hours awarded: 5
Session Information
| Name |
|---|
| Optometry Connection July 2026 |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 4 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 5 |